Format
Sort by
Items per page

Send to

Choose Destination

Search results

Items: 1 to 20 of 42

1.

Possible Biomarkers for Cancer Immunotherapy.

Otoshi T, Nagano T, Tachihara M, Nishimura Y.

Cancers (Basel). 2019 Jul 3;11(7). pii: E935. doi: 10.3390/cancers11070935. Review.

2.

Influence of the aldehyde dehydrogenase 2 polymorphism on the vasodilatory effect of nitroglycerin in infants with congenital heart disease and pulmonary arterial hypertension.

Nagano T, Ushijima K, Taga N, Takeuchi M, Kawada MA, Aizawa K, Imai Y, Fujimura A.

Eur J Clin Pharmacol. 2019 Jun 27. doi: 10.1007/s00228-019-02709-x. [Epub ahead of print]

PMID:
31250045
3.

Tenosynovitis Induced by an Immune Checkpoint Inhibitor: A Case Report and Literature Review.

Murakami S, Nagano T, Nakata K, Onishi A, Umezawa K, Katsurada N, Yamamoto M, Tachihara M, Kobayashi K, Nishimura Y.

Intern Med. 2019 Jun 27. doi: 10.2169/internalmedicine.2556-19. [Epub ahead of print]

4.

Novel cancer therapy targeting microbiome.

Nagano T, Otoshi T, Hazama D, Kiriu T, Umezawa K, Katsurada N, Nishimura Y.

Onco Targets Ther. 2019 May 13;12:3619-3624. doi: 10.2147/OTT.S207546. eCollection 2019. Review.

5.

Crucial Role of Extracellular Vesicles in Bronchial Asthma.

Nagano T, Katsurada M, Dokuni R, Hazama D, Kiriu T, Umezawa K, Kobayashi K, Nishimura Y.

Int J Mol Sci. 2019 May 27;20(10). pii: E2589. doi: 10.3390/ijms20102589. Review.

6.

Synergistic interaction of gemcitabine and paclitaxel by modulating acetylation and polymerization of tubulin in non-small cell lung cancer cell lines.

Effendi WI, Nagano T, Tachihara M, Umezawa K, Kiriu T, Dokuni R, Katsurada M, Yamamoto M, Kobayashi K, Nishimura Y.

Cancer Manag Res. 2019 Apr 29;11:3669-3679. doi: 10.2147/CMAR.S193789. eCollection 2019.

7.

Questionnaire Survey for Bronchial Asthma in Elderly Care Facilities.

Shinke H, Kamiryo H, Umezawa K, Hori S, Nakata K, Nagano T, Hazeki N, Kobayashi K, Fukabori T, Nishimura Y.

Kobe J Med Sci. 2019 Feb 13;64(5):E174-E179.

8.

Overexpression of CD 133 and BCL-2 in non-small cell lung cancer with neuroendocrine differentiation after transformation in ALK rearrangement-positive adenocarcinoma.

Koyama K, Katsurada N, Jimbo N, Tachihara M, Tamura D, Nakata K, Nagano T, Yamamoto M, Kamiryo H, Kobayashi K, Itoh T, Nishimura Y.

Pathol Int. 2019 May;69(5):294-299. doi: 10.1111/pin.12782. Epub 2019 Mar 22.

PMID:
30900377
9.

A Cross-sectional Survey of the Clinical Manifestations and Underlying Illness of Cough.

Otoshi T, Nagano T, Funada Y, Takenaka K, Nakata H, Ohnishi H, Nishiuma T, Nakajima T, Kageshita T, Tsuchiya T, Yamamoto M, Kobayashi K, Nishimura Y.

In Vivo. 2019 Mar-Apr;33(2):543-549. doi: 10.21873/invivo.11508.

10.

An Open-Label, Multi-Institutional, Randomized Study to Evaluate the Additive Effect of a Leukotriene Receptor Antagonist on Cough Score in Patients with Cough-Variant Asthma Being Treated with Inhaled Corticosteroids.

Miwa N, Nagano T, Ohnishi H, Nishiuma T, Takenaka K, Shirotani T, Nakajima T, Dokuni R, Kawa Y, Kobayashi K, Funada Y, Kotani Y, Nishimura Y.

Kobe J Med Sci. 2018 Dec 4;64(4):E134-E139.

11.

Baseline Tumor Size as a Predictive and Prognostic Factor of Immune Checkpoint Inhibitor Therapy for Non-small Cell Lung Cancer.

Katsurada M, Nagano T, Tachihara M, Kiriu T, Furukawa K, Koyama K, Otoshi T, Sekiya R, Hazama D, Tamura D, Nakata K, Katsurada N, Yamamoto M, Kobayashi K, Nishimura Y.

Anticancer Res. 2019 Feb;39(2):815-825. doi: 10.21873/anticanres.13180.

PMID:
30711962
12.

Phospholipase Cε plays a crucial role in neutrophilic inflammation accompanying acute lung injury through augmentation of CXC chemokine production from alveolar epithelial cells.

Umezawa K, Nagano T, Kobayashi K, Dokuni R, Katsurada M, Yamamoto M, Yoshikawa Y, Kataoka T, Nishimura Y.

Respir Res. 2019 Jan 11;20(1):9. doi: 10.1186/s12931-019-0975-4.

13.

Successful Treatment of ROS1-rearranged Lung Cancer Complicated by Hypertrophic Pulmonary Osteoarthropathy with Crizotinib Therapy.

Katsurada N, Tachihara M, Jimbo N, Koyama K, Nakata K, Nagano T, Yamamoto M, Kamiryo H, Kobayashi K, Nishimura Y.

Intern Med. 2019 May 15;58(10):1467-1471. doi: 10.2169/internalmedicine.1982-18. Epub 2019 Jan 10.

14.

Prognostic Value of Red Blood Cell Distribution Width in Non-small Cell Lung Cancer Treated With Anti-programmed Cell Death-1 Antibody.

Kiriu T, Yamamoto M, Nagano T, Koyama K, Katsurada M, Tamura D, Nakata K, Tachihara M, Kobayashi K, Nishimura Y.

In Vivo. 2019 Jan-Feb;33(1):213-220. doi: 10.21873/invivo.11462.

15.

Molecular Mechanisms and Targeted Therapies Including Immunotherapy for Non-Small Cell Lung Cancer.

Nagano T, Tachihara M, Nishimura Y.

Curr Cancer Drug Targets. 2018 Dec 9. doi: 10.2174/1568009619666181210114559. [Epub ahead of print]

PMID:
30526458
16.

Mechanism of Resistance to Epidermal Growth Factor Receptor-Tyrosine Kinase Inhibitors and a Potential Treatment Strategy.

Nagano T, Tachihara M, Nishimura Y.

Cells. 2018 Nov 15;7(11). pii: E212. doi: 10.3390/cells7110212. Review.

17.

Role of S1P/S1PR3 axis in release of CCL20 from human bronchial epithelial cells.

Kawa Y, Nagano T, Yoshizaki A, Dokuni R, Katsurada M, Terashita T, Yasuda Y, Umezawa K, Yamamoto M, Kamiryo H, Kobayashi K, Nishimura Y.

PLoS One. 2018 Sep 7;13(9):e0203211. doi: 10.1371/journal.pone.0203211. eCollection 2018.

18.

Bronchoscopy Using Virtual Navigation and Endobronchial Ultrasonography with a Guide Sheath (EBUS-GS) with or without Fluoroscopy for Peripheral Pulmonary Lesions.

Tachihara M, Tamura D, Kiriu T, Tokunaga S, Hatakeyama Y, Shinke H, Nagano T, Nakata K, Hazeki N, Kamiryo H, Kobayashi K, Nishimura Y.

Kobe J Med Sci. 2018 Mar 27;63(4):E99-E104.

19.

Lung squamous cell carcinoma associated with hypoparathyroidism with sensorineural deafness and renal dysplasia syndrome: a case report.

Kojima M, Nagano T, Nakata K, Hara S, Katsurada N, Yamamoto M, Tachihara M, Kamiryo H, Kobayashi K, Usui T, Nishimura Y.

Onco Targets Ther. 2018 Mar 20;11:1595-1599. doi: 10.2147/OTT.S161420. eCollection 2018.

20.

The time-series behavior of neutrophil-to-lymphocyte ratio is useful as a predictive marker in non-small cell lung cancer.

Kiriu T, Yamamoto M, Nagano T, Hazama D, Sekiya R, Katsurada M, Tamura D, Tachihara M, Kobayashi K, Nishimura Y.

PLoS One. 2018 Feb 15;13(2):e0193018. doi: 10.1371/journal.pone.0193018. eCollection 2018. Review.

Supplemental Content

Loading ...
Support Center